Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 8, Issue 12 (2019)

Crohn’s disease: Current approaches in the management and remission

Author(s):
P Sailaja Rao and Pingili Divya
Abstract:
Crohn’s disease (CD), characterized as inflammatory bowel disease (IBD), is a chronic disease that affects the lining of digestive tract and includes lifelong therapy. High incidence of this disease is witnessed in western countries like USA, Canada, UK and is slightly apprehending in Asian countries. Medical treatments for IBD are restricted and were aimed at bestowing symptomatic amelioration. When conventional treatments are not responding in patients suffering from Crohn’s disease, chemotherapy with drugs like infliximab, adalimumab, methotrexate, and cyclophosphamide may aid in treating the symptoms and inclines the disease into remission. Though medication is helping out in the maintenance of Crohn’s, the lifestyle improvement can support in the better management of the disease. An improved perceptive of pathological mechanisms endeavors new castles in air for tailored therapies. In the present review, emphasis was laid on portrayal of pathological mechanisms, newer diagnostic techniques, chemotherapy and the prominence of diet, exercise, yoga and pranayama in the remission of Crohn’s disease.
Pages: 54-60  |  174 Views  11 Downloads
How to cite this article:
P Sailaja Rao, Pingili Divya. Crohn’s disease: Current approaches in the management and remission. Pharma Innovation 2019;8(12):54-60.
The Pharma Innovation Journal